Saks Samuel R 4
4 · Protagonist Therapeutics, Inc · Filed May 16, 2019
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2019-05-15+45,000→ 45,000 totalExercise: $10.80Exp: 2029-05-14→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 48 equal monthly installments following the date of grant.